网上平台被黑不给取款

EN
News Releases

News Releases

News Releases

Home>News Releases

Headlines

微信图片_20201223103813.jpg

CR Double-Crane acquired 38.7% interest of Dongying Tiandong Pharmaceutical Co., Ltd.’s

CR Double-Crane acquired 38.7% interest of Dongying Tiandong Pharmaceut...


  On December 22, 2020, the signing ceremony between CR Double-Crane and Shandong Haike was held in Dongying, Shandong, and the “Dongying Tiandong Pharmaceutical Equity Transfer...

  On December 22, 2020, the signing ceremony between CR Double-Crane and Shandong Haike was held in Dongying, Shandong, and the “Dong...

Detailed>>

Detailed +

2021.03

2021.03.31

CR Sanjiu cooperate with Ryukakusan to protect throat health in China

CR Sanjiu cooperate with Ryukakusan to protect throat health in China


  On March 31, CR Sanjiu and Ryukakusan, a leading Japanese brand for throat drugs, officially entered into a strategic cooperation ag...

2021.07

2021.07.21

2021.07

2021.07.20

CR Pharmaceutical proposed to acquire 10.0% stake in Immunotech Biopharm

CR Pharmaceutical proposed to acquire 10.0% stake in Immunotech Biopharm


  On 20 July, Beijing Pharmaceutical Investment and Management (BVI) Limited, a wholly-owned subsidiary of the Company and as a purcha...

2021.07

2021.07.12

CR Biopharmaceutical and Biocytogen reach a comprehensive strategic cooperation for the development of multiple target antibody drugs

CR Biopharmaceutical and Biocytogen reach a comprehensive strategic coo...


  On July 12, China Resources Biopharmaceutical Co., Ltd. (hereafter referred to as CR Biopharmaceutical) and Biocytogen Pharmaceutica...

2021.07

2021.07.07

CR Pharmaceutical’s proposed acquisition of a controlling stake in Boya Bio-pharmaceutical[2019 report] was approved by the SASAC

CR Pharmaceutical’s proposed acquisition of a controlling stake in Boy...


  On July 7, China Resources Pharmaceutical Group Limited (Stock Code: 3320.HK) announced the company had received the approval letter...

2021.06

2021.06.04

Runsheng’s ANDA application to FDA for Advair Diskus Generic Grug was given “Priority Review”

Runsheng’s ANDA application to FDA for Advair Diskus Generic Grug was ...


  On June 1, China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (“CR Sanjiu”; Stock Code: 000999.SZ), a subsidiary of China R...

2021.05

2021.05.20

CR Biopharmaceutical and Hybio Pharmaceutical signed a cooperation agreement

CR Biopharmaceutical and Hybio Pharmaceutical signed a cooperation agre...


  On the afternoon of May 20th, the signing ceremony of the cooperation agreement between China Resources Biopharmaceutical Co., Ltd. ...
Back to Top